United States · FDA National Drug Code directory
UPTRAVI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46014-6140_352c749f-c592-ad4c-e063-6294a90a3751
- Product NDC
- 46014-6140
- Form
- CAPSULE
- Composition / generic term
- UPTRAVI
- Labeler
- Excella GmbH & Co. KG
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20151222
- Source listing expiry
- 20261231
Source-listed ingredients
- SELEXIPAG — 1.4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (46014-6140-6) · 46014-6140-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →